Clinical trial fraud is not an uncommon problem. Though it is difficult to comprehend, it’s something that should not be ignored. Despite the problem, there is some hope. According to industry insiders, regulatory scrutiny is starting to ramp up….
Designing and carrying out clinical trials has remained relatively unchanged over the last 10-20 years; most biopharmas outsource their studies to a single contract research organization (CRO). The CRO then manages most aspects of the clinical trial, including the…
